meta-analysis for demonstrating superiority or inferiority.
29
We applied TSA to re-examine the three randomized studies 30 evaluated by Lee et al. 1 Our analysis considered the end-point 31 of hemoglobin improvement. Our main assumptions included 32 two-sided testing, risk of type 1 error = 5%, and power = 80%.
33
The intervention effect was set at an anticipated absolute Figure 1 Trial sequential analysis based on the three available randomized trials. In the z-curve (represented in blue), individual trials correspond to individual segments; trials are plotted in chronological order (from left to right) with the x-axis indicating the cumulative number of patients; the starting point of the z-curve is at x = 0, i.e. inclusion of no trials; at the cumulative number of 333 included patients, the curve has already crossed the red boundaries thus reaching the superiority area; on the other hand, the third trial leads the final position of the z-curve at limits between superiority and inconclusive result. Abbreviations and symbols: red lines are the boundaries for superiority or inferiority while green lines are the boundaries for futility. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
improvement in hemoglobin of at least 10 g/L. 1) Repetition of the meta-analysis carried out by Lee et al.: this repetition had the propose to verify the agreement of all trial-specific data between
Lee and coworkers' meta-analysis and our re-analysis. Graph and statistical calculations according to the OMA software.
